US 10583145
Methods and compositions comprising ursolic acid and/or resveratrol for treating diabetes, or cancer
granted A61KA61K31/05A61K31/19
Quick answer
US patent 10583145 (Methods and compositions comprising ursolic acid and/or resveratrol for treating diabetes, or cancer) held by The Board of Regents of the University of Texas System expires Mon Mar 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Mar 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/05, A61K31/19, A61K31/56, A61K9/0053